Free Trial
NYSEAMERICAN:STXS

Stereotaxis (STXS) Stock Price, News & Analysis

Stereotaxis logo
$2.70 -0.01 (-0.37%)
As of 10:28 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Stereotaxis Stock (NYSEAMERICAN:STXS)

Key Stats

Today's Range
$2.69
$2.72
50-Day Range
$2.12
$2.90
52-Week Range
$1.54
$3.05
Volume
29,152 shs
Average Volume
449,085 shs
Market Capitalization
$244.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Stereotaxis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
14th Percentile Overall Score

STXS MarketRank™: 

Stereotaxis scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Stereotaxis.

  • Earnings Growth

    Earnings for Stereotaxis are expected to grow in the coming year, from ($0.26) to ($0.16) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Stereotaxis is -9.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Stereotaxis is -9.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Stereotaxis has a P/B Ratio of 134.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Stereotaxis' valuation and earnings.
  • Percentage of Shares Shorted

    4.68% of the float of Stereotaxis has been sold short.
  • Short Interest Ratio / Days to Cover

    Stereotaxis has a short interest ratio ("days to cover") of 7.3.
  • Change versus previous month

    Short interest in Stereotaxis has recently decreased by 12.81%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Stereotaxis does not currently pay a dividend.

  • Dividend Growth

    Stereotaxis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.68% of the float of Stereotaxis has been sold short.
  • Short Interest Ratio / Days to Cover

    Stereotaxis has a short interest ratio ("days to cover") of 7.3.
  • Change versus previous month

    Short interest in Stereotaxis has recently decreased by 12.81%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Stereotaxis this week, compared to 2 articles on an average week.
  • Search Interest

    4 people have searched for STXS on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Stereotaxis insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.77% of the stock of Stereotaxis is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    45.35% of the stock of Stereotaxis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Stereotaxis' insider trading history.
Receive STXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stereotaxis and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

STXS Stock News Headlines

What's the Best Way to Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.tc pixel
Stereotaxis to Present at Upcoming Investor Conferences
See More Headlines

STXS Stock Analysis - Frequently Asked Questions

Stereotaxis' stock was trading at $2.29 at the beginning of the year. Since then, STXS stock has increased by 17.5% and is now trading at $2.69.

Stereotaxis Inc. (NYSEAMERICAN:STXS) posted its earnings results on Monday, November, 11th. The company reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.05) by $0.03. The firm earned $9.20 million during the quarter, compared to the consensus estimate of $6.80 million. Stereotaxis had a negative trailing twelve-month return on equity of 440.00% and a negative net margin of 73.43%.
Read the conference call transcript
.

Top institutional shareholders of Stereotaxis include Geode Capital Management LLC (1.72%), Warberg Asset Management LLC (1.40%), Prescott Group Capital Management L.L.C. (1.32%) and State of Wyoming (0.43%).
View institutional ownership trends
.

Shares of STXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stereotaxis investors own include Tesla (TSLA), Advanced Micro Devices (AMD), NVIDIA (NVDA), Intel (INTC), Meta Platforms (META), JPMorgan Chase & Co. (JPM) and Netflix (NFLX).

Company Calendar

Last Earnings
11/11/2024
Today
9/03/2025
Next Earnings (Estimated)
11/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NYSEAMERICAN:STXS
CIK
1289340
Employees
130
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$24.05 million
Net Margins
-73.43%
Pretax Margin
-73.43%
Return on Equity
-440.00%
Return on Assets
-50.62%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.06
Quick Ratio
0.59

Sales & Book Value

Annual Sales
$26.92 million
Price / Sales
9.13
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.02 per share
Price / Book
135.50

Miscellaneous

Outstanding Shares
90,650,000
Free Float
74,545,000
Market Cap
$245.66 million
Optionable
Not Optionable
Beta
1.61
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSEAMERICAN:STXS) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners